Trial Profile
Effect of Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Therapy on the Pharmacokinetics of Rosuvastatin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2014
Price :
$35
*
At a glance
- Drugs Asunaprevir/becabluvir/daclatasvir (Primary) ; Beclabuvir; Rosuvastatin
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 17 Jul 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 14 Apr 2014 New trial record